ExCEEd Orphan announces opening of the next non-EU affiliate in North Macedonia
The ExCEEd Orphan s.r.o., a Czech based multinational company providing full business solutions
ExCEEd Orphan and World Orphan Drug Congress in Barcelona
“During upcoming World Orphan Drug Congress in Barcelona (https://www.terrapinn.com/conference/world-orphan-drug-congress/agenda.stm), Jiri Hermanek, CEO of ExCEEd Orphan (https://www.exceedorphan.com/)
ExCEEd Orphan Announces Signature of an Exclusive Distribution Agreement with Mirum Pharmaceuticals for Marketing and Distribution of LIVMARLI™ (maralixibat) in Central and Eastern Europe
ExCEEd Orphan Distribution d.o.o., a Croatia based fully-owned subsidiary of ExCEEd Orphan s.r.o.,
ExCEEd Orphan announces signature of Distribution Agreement with Komtur Pharmaceuticals for Czech Republic, Poland and Slovakia
ExCEEd Orphan Distribution d.o.o., a Croatia based fully owned subsidiary of ExCEEd Orphan
ExCEEd Orphan announces signature of an exclusive Distribution Agreement with Diurnal for marketing and distribution of Alkindi® and Efmody® in Central and Eastern Europe
ExCEEd Orphan Distribution d.o.o., a Croatia based fully-owned subsidiary of ExCEEd Orphan s.r.o.,
ExCEEd Orphan announces opening of its first non-EU affiliate in Serbia
ExCEEd Orphan s.r.o., a Czech based multinational company providing full business solutions for
ExCEEd Orphan s.r.o. announces cooperation with myTomorrows for selected Central and Eastern European countries
ExCEEd Orphan s.r.o., a company providing full range of market entry services, has
Neobiomics AB and ExCEEd Orphan s.r.o. announce exclusive cooperation for Central and Eastern Europe
Stockholm, Sweden, 21 May, 2021 – Neobiomics AB and ExCEEd Orphan s.r.o. have
ExCEEd Orphan features in Pharma Tech Outlook’s TOP 10 Marketing Service Companies in Europe!
Pharma Tech Outlook, the monthly publication which brings forth real-world solutions, news, and